Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients
Reflect Scientific (RSCF) has secured over $250,000 in new orders for its high-performance freezer systems from international biotech and pharmaceutical clients. These follow-on orders demonstrate growing global adoption of the company's proprietary cooling technologies, with clients expanding implementation across multiple facilities after initial successful deployments.
The company's ultra-low-temperature freezers, known for energy efficiency and reliable operation, serve critical roles in pharmaceutical R&D, vaccine storage, and biotech manufacturing. These orders represent expanding market penetration in global life sciences markets, supporting cold chain operations.
Reflect Scientific (RSCF) ha ottenuto oltre 250.000$ in nuovi ordini per i suoi sistemi di congelamento ad alte prestazioni da clienti internazionali nel settore biotecnologico e farmaceutico. Questi ordini successivi dimostrano una crescente adozione globale delle tecnologie di raffreddamento proprietarie dell'azienda, con clienti che ampliano l'implementazione in più strutture dopo i primi successi.
I congelatori a ultra-basse temperature dell'azienda, noti per l'efficienza energetica e l'affidabilità, svolgono ruoli fondamentali nella ricerca e sviluppo farmaceutica, nella conservazione dei vaccini e nella produzione biotecnologica. Questi ordini indicano un'espansione della penetrazione nei mercati globali delle scienze della vita, supportando le operazioni della catena del freddo.
Reflect Scientific (RSCF) ha asegurado más de $250,000 en nuevos pedidos para sus sistemas de congelación de alto rendimiento de clientes internacionales en biotecnología y farmacéutica. Estos pedidos adicionales demuestran una creciente adopción global de las tecnologías de enfriamiento propietarias de la empresa, con clientes que amplían su implementación en múltiples instalaciones tras despliegues iniciales exitosos.
Los congeladores ultrabajas temperaturas de la empresa, conocidos por su eficiencia energética y operación confiable, desempeñan roles críticos en I+D farmacéutica, almacenamiento de vacunas y fabricación biotecnológica. Estos pedidos representan una mayor penetración en los mercados globales de ciencias de la vida, apoyando las operaciones de la cadena de frío.
Reflect Scientific (RSCF)는 국제 생명공학 및 제약 고객으로부터 고성능 냉동 시스템에 대해 25만 달러 이상의 신규 주문을 확보했습니다. 이 후속 주문들은 회사의 독자적인 냉각 기술이 전 세계적으로 점점 더 많이 채택되고 있음을 보여주며, 고객들이 초기 성공적인 도입 후 여러 시설로 확장하고 있음을 나타냅니다.
회사의 초저온 냉동기는 에너지 효율성과 신뢰성 있는 작동으로 알려져 있으며, 제약 연구개발, 백신 보관, 생명공학 제조에서 중요한 역할을 합니다. 이 주문들은 전 세계 생명과학 시장에서의 시장 침투 확대를 의미하며, 콜드체인 운영을 지원합니다.
Reflect Scientific (RSCF) a obtenu plus de 250 000 $ de nouvelles commandes pour ses systèmes de congélation haute performance auprès de clients internationaux du secteur biotechnologique et pharmaceutique. Ces commandes supplémentaires témoignent de l’adoption croissante à l’échelle mondiale des technologies de refroidissement propriétaires de l’entreprise, les clients étendant leur déploiement à plusieurs sites après des premiers succès.
Les congélateurs à ultra-basse température de la société, réputés pour leur efficacité énergétique et leur fonctionnement fiable, jouent un rôle crucial dans la R&D pharmaceutique, le stockage des vaccins et la production biotechnologique. Ces commandes reflètent une pénétration accrue sur les marchés mondiaux des sciences de la vie, soutenant les opérations de la chaîne du froid.
Reflect Scientific (RSCF) hat über 250.000$ an neuen Aufträgen für seine Hochleistungs-Gefriersysteme von internationalen Biotech- und Pharma-Kunden erhalten. Diese Folgeaufträge zeigen die wachsende weltweite Akzeptanz der firmeneigenen Kühltechnologien, wobei Kunden nach erfolgreichen ersten Einsätzen die Nutzung auf mehrere Standorte ausweiten.
Die ultratiefkühlgeräte des Unternehmens, bekannt für Energieeffizienz und zuverlässigen Betrieb, spielen eine entscheidende Rolle in der pharmazeutischen Forschung und Entwicklung, der Impfstofflagerung und der Biotech-Produktion. Diese Aufträge spiegeln eine zunehmende Marktdurchdringung in den globalen Life-Sciences-Märkten wider und unterstützen die Kühlkettenlogistik.
- Secured over $250,000 in new orders for freezer systems
- Repeat orders from existing customers indicate product satisfaction and reliability
- Expanding international market presence in biotech and pharma sectors
- Growing adoption of proprietary cooling technologies across multiple client facilities
- None.
OREM, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic and refrigeration technologies, announced today it has received over
These follow-on orders underscore the continued global adoption of Reflect Scientific’s proprietary cooling technologies. Client facilities in multiple regions are now implementing the systems after initial success at earlier locations.
“Our freezers are purpose-built for the most demanding environments,” said Mr. Kim Boyce, CEO of Reflect Scientific. “It’s rewarding to see returning customers expand their use of our technology across international sites. This reflects both the performance of our systems and the trust we’ve built with our clients.”
Reflect’s ultra-low-temperature freezers are known for energy efficiency, durability, and dependable operation. They serve key roles in pharmaceutical R&D, vaccine storage, and biotech manufacturing. The Company continues to grow its footprint in global life sciences markets with solutions that support safe, scalable, and sustainable cold chain operations.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”
Contact Investor Relations 801-607-1039 info@reflectscientific.com
FAQ
What is the value of new freezer orders received by Reflect Scientific (RSCF) in May 2025?
What are the main applications of Reflect Scientific's (RSCF) freezer systems?
What are the key features of Reflect Scientific's (RSCF) ultra-low-temperature freezers?
Who are the customers placing new orders for Reflect Scientific's (RSCF) freezer systems?
